Business

Posting of the Annual Report and Notice of AGM

Posting of the Annual Report and Notice of AGM.

articleEco Animal Health Group PlcAugust 16, 20245/company/eco-animal-health-group-plc/news/posting-of-the-annual-report-and-notice-of-agm
Posting of the Annual Report and Notice of AGM

About this update from Eco Animal Health Group Plc

[{"type":"text","content":"\n\n16 August 2024\n\nECO Animal Health Group plc\n(\"ECO\" or the \"Company\")\n \nPosting of the Annual Report and Notice of AGM\nECO Animal Health Group plc (AIM: EAH), a rapidly growing global animal health company with a portfolio of marketed veterinary products and a maturing proprietary R&D pipeline, announces that its Annual Report and Accounts for the year ended 31 March 2024 and Notice of Annual General Meeting (\"AGM\") together with Form of Proxy have today been sent to shareholders who have elected to receive hard copies by post.\nThe Annual Report and Accounts is available on the Company's website at https://ecoanimalhealth.com/investors/.\nThe Company will hold its AGM at The Grange, 100 High Street, London, N14 6BN on Thursday, 26 September 2024 at 9:00 am.\nA copy of the Notice of AGM and Form of Proxy will be available on the Company's website at https://ecoanimalhealth.com/investors/.\n-Ends-\nFor further information please contact:\n \n\n\n\n\n\n\n\n\nECO Animal Health Group plc\nDavid Hallas (CEO)\nChristopher Wilks (CFO)\n\n\n\n020 8447 8899\n \n\n\n\n\nSinger Capital Markets (Nominated Adviser & Joint Broker)\nPhil Davies\nSam Butcher\n\n\n020 7496 3000\n\n\n\n\nInvestec (Joint Broker)\nGary Clarence\nLydia Zychowska\n\n\n020 7597 5970\n \n \n\n\n\n\nEquity Development\nHannah Crowe\nMatt Evans\n\n\n020 7065 2692\n\n\n\n\nICR Consilium (Financial PR)\nMary-Jane Elliott\nJessica Hodgson\n\n\n020 3709 5700\[email protected]\n \n\n\n\n\n\n\n\n\n\n\n\n\nAbout ECO Animal Health\nECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.\n \nHeadquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.\n \nOur lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry. \nClick here for more information: https://ecoanimalhealth.com\n \n\n","length":5427,"tagName":"div"}]

More updates from Eco Animal Health Group Plc